449 related articles for article (PubMed ID: 32986507)
1. Periclavicular Lymph Node Activation Maintains the Lymphatic Circulation of Upper Extremity Following Breast Cancer Surgery with Axillary Lymph Node Dissection.
Kang SH; Lee DG
Lymphat Res Biol; 2021 Jun; 19(3):256-260. PubMed ID: 32986507
[No Abstract] [Full Text] [Related]
2. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
[TBL] [Abstract][Full Text] [Related]
3. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
[TBL] [Abstract][Full Text] [Related]
4. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
[TBL] [Abstract][Full Text] [Related]
5. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
Trials; 2013 Apr; 14():111. PubMed ID: 23782712
[TBL] [Abstract][Full Text] [Related]
6. Findings of lymphoscintigraphy and the severity of lymphedema according to the extent of axillary lymph node dissection.
Kim JB; Lee DG
Asian J Surg; 2020 Jan; 43(1):95-101. PubMed ID: 30857863
[TBL] [Abstract][Full Text] [Related]
7. Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients.
Poulsen L; Kaur M; Jacobsen AL; Bjarnesen MP; Bjarnesen AP; Klassen AF; Pusic AL; de Vries CEE; Sørensen JA
Breast Cancer Res Treat; 2022 Jan; 191(1):87-96. PubMed ID: 34643834
[TBL] [Abstract][Full Text] [Related]
8. Lymphoscintigraphy in patients with breast cancer-related lymphedema after sentinel lymph node dissection and axillary radiation therapy.
Oh SH; Kim JH; Seong ST; Park JY; Lee JH; Kim GC; Jeong HJ; Sim YJ
Medicine (Baltimore); 2022 Dec; 101(49):e31985. PubMed ID: 36626428
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
10. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial].
Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800
[No Abstract] [Full Text] [Related]
11. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.
Abdelhamid MI; Bari AA; Farid MI; Nour H
Int J Surg; 2020 Mar; 75():174-178. PubMed ID: 32059974
[TBL] [Abstract][Full Text] [Related]
13. Lymphedema Incidence After Axillary Lymph Node Dissection: Quantifying the Impact of Radiation and the Lymphatic Microsurgical Preventive Healing Approach.
Johnson AR; Kimball S; Epstein S; Recht A; Lin SJ; Lee BT; James TA; Singhal D
Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S234-S241. PubMed ID: 30855393
[TBL] [Abstract][Full Text] [Related]
14. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
15. Lymph drainage studied by lymphoscintigraphy in the arms after sentinel node biopsy compared with axillary lymph node dissection following conservative breast cancer surgery.
Celebioglu F; Perbeck L; Frisell J; Gröndal E; Svensson L; Danielsson R
Acta Radiol; 2007 Jun; 48(5):488-95. PubMed ID: 17520423
[TBL] [Abstract][Full Text] [Related]
16. [Functional axillary dissection based on lymphatic drainage for breast cancer: a single center randomized clinical trial].
Yuan QQ; Hou JX; Zhou R; Zou SQ; Wu GS
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(32):2531-2536. PubMed ID: 34407579
[No Abstract] [Full Text] [Related]
17. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
Wijaya WA; Peng J; He Y; Chen J; Cen Y
Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
[TBL] [Abstract][Full Text] [Related]
18. Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Che Bakri NA; Kwasnicki RM; Khan N; Ghandour O; Lee A; Grant Y; Dawidziuk A; Darzi A; Ashrafian H; Leff DR
Ann Surg; 2023 Apr; 277(4):572-580. PubMed ID: 35946806
[TBL] [Abstract][Full Text] [Related]
19. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
Jia M; Pan L; Yang H; Gao J; Guo F
Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
[TBL] [Abstract][Full Text] [Related]
20. Lymph Node Positivity of Axillary Reverse Mapping Lymph Nodes at the Time of Axillary Lymph Node Dissection: Two-Site Prospective Trial.
Benolken MM; McLaughlin S; Piltin M; Mrdutt M; Li Z; Jakub JW
Ann Surg Oncol; 2023 Oct; 30(10):6042-6049. PubMed ID: 37466868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]